Listed on
(Coverage)
JCR2009-2023
SJR2008-2020;2022-2023
CiteScore2011-2023
SCIE2010-2024
SCOPUS2017-2024
MEDLINE2016-2024
DOAJ2018-2024
EMBASE2016-2024
OA Info.
OA |
oa mark
based on the information
- 2018;2019;2020;2021;2022;2023;2024;2025;
|
Keywords |
cancer, molecular biology, molecular genetics |
Review Process |
Open peer review |
Journal info. pages |
|
Licences |
CC BY |
Copyrights |
Yes |
DOAJ Coverage |
Added on Date : 2017-10-27T11:00:26Z |
Subject(s) |
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Country
USA
Aime & Scopes
Molecular Oncology is a monthly online-only Open Access journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research.
The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients. Submissions that meet the high standards of the journal are sent for rigorous, single-blind peer review by experts in the field.
Topics include, but are not limited to:
/// Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.
/// Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.
/// Biomarkers: diagnosis, prognosis, stratification and efficacy.
/// Cancer genetics, epigenetics, and genomic instability.
/// Minimal residual disease, pre-malignant lesions.
/// Cancer micro-environment.
/// Molecular pathology.
/// Tumour immunology.
/// Translational research.
/// Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).
/// Chemotherapy, radiotherapy and surgery.
/// Clinical pharmacology.
/// Clinical trials, integration of basic science into cancer clinical trials.
/// Molecular epidemiology.